Experimental evaluation of the nonselective and selective TMEM16 family calcium-activated chloride channel blockers in the airways

European Pharmaceutical Journal · Published 2023-09-30 · DOI 10.2478/afpuc-2023-0016

Authors being retrieved — see the publisher record. https://doi.org/10.2478/afpuc-2023-0016

Abstract

The family of calcium-activated chloride channels, TMEM16, plays a significant role in contributing to the pathogenesis of airway inflammatory diseases. Targeting these ion channels and aiming to modulate them may provide an interesting new approach to the therapy of these potentially fatal diseases.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2023

Related articles